Cargando…

Reply to ‘Antipsychotics with similar association kinetics at dopamine D(2) receptors differ in extrapyramidal side-effects’

Detalles Bibliográficos
Autores principales:	Sykes, David A., Lane, J. Robert, Szabo, Monika, Capuano, Ben, Javitch, Jonathan A., Charlton, Steven J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120895/ https://www.ncbi.nlm.nih.gov/pubmed/30177696 http://dx.doi.org/10.1038/s41467-018-05678-4

Ejemplares similares

Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D(2) receptors
por: Sykes, David A., et al.
Publicado: (2017)

Antipsychotics with similar association kinetics at dopamine D(2) receptors differ in extrapyramidal side-effects
por: Zeberg, Hugo, et al.
Publicado: (2018)

ANTIPSYCHOTIC-INDUCED VACUOUS CHEWING MOVEMENTS AND EXTRAPYRAMIDAL SIDE-EFFECTS ARE HIGHLY HERITABLE IN MICE
por: Crowley, James J., et al.
Publicado: (2010)

Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis
por: Siafis, Spyridon, et al.
Publicado: (2023)

Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side Effects
por: Ohno, Yukihiro, et al.
Publicado: (2019)

Second-Generation Antipsychotics and Extrapyramidal Adverse Effects
por: Divac, Nevena, et al.
Publicado: (2014)

Antipsychotic-induced extrapyramidal side effects: A systematic review and meta-analysis of observational studies
por: Ali, Tilahun, et al.
Publicado: (2021)

Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics
por: Boloc, Daniel, et al.
Publicado: (2018)

Case report: Open bite as an extrapyramidal side effect with aripiprazole, a dopamine partial agonist
por: Sumi, Satoko, et al.
Publicado: (2022)

Akathisia as an Extrapyramidal Side Effect of Fluoxetine
por: Ajufo, Ijeoma, et al.
Publicado: (2021)

Antipsychotics and COVID-19: the debate goes on – Authors' reply
por: De Picker, Livia, et al.
Publicado: (2021)

The role of kinetic context in apparent biased agonism at GPCRs
por: Klein Herenbrink, Carmen, et al.
Publicado: (2016)

Extrapyramidal side effects with low doses of amisulpride
por: Mandal, Nikhiles, et al.
Publicado: (2014)

Author Correction: Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics
por: Boloc, Daniel, et al.
Publicado: (2019)

Does antipsychotic use mediate the effect of psychiatric disorders on COVID-19? – Authors' reply
por: Yang, Huazhen, et al.
Publicado: (2021)

Exercise and Worsening of Extrapyramidal Symptoms during Treatment with Long-Acting Injectable Antipsychotics
por: Kim, David D., et al.
Publicado: (2021)

Acute Extrapyramidal Side Effects from Smoked Haloperidol
por: Pham, Angeline, et al.
Publicado: (2021)

Antipsychotic-induced catatonia and neuroleptic malignant syndrome: the dark side of the moon
por: Hirjak, Dusan, et al.
Publicado: (2021)

Pharmacokinetic–Pharmacodynamic Modeling of Severity Levels of Extrapyramidal Side Effects With Markov Elements
por: Pilla Reddy, V, et al.
Publicado: (2012)

Author's Reply. RE: An intercultural perspective towards supporting antipsychotic medication adherence in clinical practice
por: Zacharia, Tharun
Publicado: (2023)

Study on risk factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia
por: Weng, Jiajun, et al.
Publicado: (2019)

Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate
por: Joubert, Francois-Pierre, et al.
Publicado: (2021)

Management of Psychosis in the Setting of Binge Eating, Mania, and Extrapyramidal Side Effects
por: Tamayo Acosta, Jean C, et al.
Publicado: (2022)

Extrapyramidal Side Effects with Chronic Atypical Antipsychotic Can Be Predicted by Labeling Pattern of FosB and phosphoThr(34)-DARPP-32 in Nucleus Accumbens
por: Prieto, Sonia G., et al.
Publicado: (2023)

Reply
por: Hancock, S., et al.
Publicado: (2020)

Reply to: Magnesium sulphate intravenously reduces tachycardia side-effects of β(2)-agonists
por: Powell, Colin, et al.
Publicado: (2022)

Extrapyramidal side-effects of low-dose aripiprazole in an 11-year-old child
por: Mohapatra, Satyakam
Publicado: (2016)

Extrapyramidal Side Effects with Low Dose Amisulpride: A Report of Two Cases
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2016)

Extrapyramidal side effect of donepezil hydrochloride in an elderly patient: A case report
por: Li, Hong-Chun, et al.
Publicado: (2020)

Erratum: Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate
por: Joubert, Francois-Pierre, et al.
Publicado: (2021)

Reply
por: Forde, Justin J., et al.
Publicado: (2021)

Differentiating Between Lithium Tremors and Extrapyramidal Tremors in a Patient on Long-Term Antipsychotics and Lithium Medication
por: Singh, Gurraj, et al.
Publicado: (2023)

Reply
por: Lee, Daniel J., et al.
Publicado: (2022)

Extrapyramidal side effects and suicidal ideation under fluoxetine treatment: a case report
por: Christodoulou, Christos, et al.
Publicado: (2010)

Reply
por: Roscam Abbing, Reinout L.P., et al.
Publicado: (2020)

In reply:
por: Augustine, James J., et al.
Publicado: (2004)

Author's reply
por: Babu, P Ravindra, et al.
Publicado: (2017)

Reply
por: Patel, Yogin, et al.
Publicado: (2020)

Reply
por: Hudert, Christian A., et al.
Publicado: (2022)

Reply
por: Brenner, Erica J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fsd1mlcn3n4km56a7bcc7kaaft